https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-f-utilization-matrix-matrices-1-to-10-com-parts-1-to-23-x-classes-i-ii-iii-v-x-use-not-price-com-x-category-b-assets-in-z/ 2026-09-19T20:01:26Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part F — Utilization Matrix [Matrices 1 to 10]: COM (Parts 1 to 23) x Classes I, II, III, V, X. Use, not price. COM x Category B Assets in Z 2026-09-19T20:01:26Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-e-registry-of-category-b-assets-one-table-fair-value-one-z-phase-2-valuation-event-six-months-after-t1-combined-with-pairing-sits-under/ 2026-09-19T19:42:08Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part E — Registry of Category B assets. One table. Fair value = one Z (Phase-2 Valuation Event) six months after T1. "Combined-with ..." (Pairing) sits under that table. Combined-with is Group 1 and Group 2, not Group 2 only. 2026-09-19T19:42:08Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-d-chart-4-grand-total-650-m-maps-that-must-not-be-read-as-a-second-invoice/ 2026-09-19T19:52:53Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part D — Chart 4 Grand Total $650 M. Adjacency Maps that must not be read as a second invoice. 2026-09-19T19:31:38Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-c-narrative-only-category-b-assets-show-0-on-chart-4-transfer-at-t1-is-not-optionality/ 2026-09-19T19:24:38Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part C — Narrative only. Category B Assets show $0 on Chart 4. Transfer at T1 is not optionality. 2026-09-19T19:24:38Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-b-product-layer-already-on-chart-4-includes-com-part-21-ext-c-5-at-30-0-m/ 2026-09-19T19:18:53Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part B — Product layer already on Chart 4. Includes COM Part 21 / EXT-C.5 at $30.0 M. 2026-09-19T19:18:53Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/part-a-category-a-assets-priced-stack-phase-1-on-chart-4-includes-com-part-13-ext-c-4-at-32-5-m-table-1-lives-here/ 2026-09-19T19:06:52Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Part A — Category A assets. Priced stack. Phase-1 on Chart 4. Includes COM Part 13 / EXT-C.4 at $32.5 M. Table 1 lives here. 2026-09-19T19:06:52Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-22-valuation-full-breakdown-supporting-calculations-total-valuation-of-lpbi-portfolio-of-ip-assets-parts-a-b-c-d-e-f/ 2026-09-20T01:12:59Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Appendix C-22: Valuation Full Breakdown & Supporting Calculations Total Valuation of LPBI Portfolio of IP Assets: Parts A, B, C, D, E, F 2026-09-19T18:54:22Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-21-complete-inventory-list-for-transfer-of-ownership-all-valuables-10-classes-com-parts-1-23-13-hidden-gems-with-revival-potential/ 2026-09-19T18:31:44Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Appendix C-21: Complete Inventory List for Transfer of Ownership — All Valuables – 10 Classes [COM Parts (1–23)] + 13 Hidden Gems with Revival Potential 2026-09-19T18:31:44Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/appendix-c-valuation-financials/appendix-c-20-three-legged-stool-strategy-valuation-contribution/ 2026-09-19T18:30:00Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Appendix C-20: Three-Legged Stool Strategy – Valuation Contribution 2026-09-19T18:07:07Z Blog